title: HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective.
abstract: The efficacy of combination therapy (antiretroviral therapy--ARV) is demonstrated by the high rates of viral suppression achieved in most treated HIV patients. Whereas contemporary treatments may continuously suppress HIV replication, they do not eliminate the latent reservoir, which can reactivate HIV infection if ARV is discontinued. The persistence of HIV proviral DNA and infectious viruses in CD4+ T cells and others cells has long been considered a major obstacle in eradicating the HIV virus in treated patients. Moreover, recent studies have demonstrated the persistence of HIV replication at low copies in most patients on suppressive ARV. The source of this 'residual viraemia' and whether it declines over years of therapy remain unknown. Similarly, little is known regarding the biological relationships between the HIV reservoir and viral replication at low copies. The question of whether this 'residual viraemia' represents active replication or the release of non-productive virus from the reservoir has not been adequately resolved. From a clinical perspective, both the quantification of the HIV reservoir and the detection of low levels of replication in full-responder patients on prolonged ARV may provide important information regarding the effectiveness of treatment and the eradication of HIV. To date, the monitoring of these two parameters has been conducted only for research purposes; the routine use of standardised tests procedure is lacking. This review aims to assess the current data regarding the correlation between HIV replication at low copies and the HIV reservoir and to provide useful information for clinicians.
authors.affiliation: Clinical Infectious Diseases, Tor Vergata University, V. Montpellier 1, 00133, Roma, Italy. sarmati@med.uniroma2.it.
authors.forename: Loredana
authors.initials: L
authors.lastname: Sarmati
authors.forename: Gabriella
authors.initials: G
authors.lastname: D'Ettorre
authors.forename: Saverio Giuseppe
authors.initials: SG
authors.lastname: Parisi
authors.forename: Massimo
authors.initials: M
authors.lastname: Andreoni
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006678:HIV / Q000187:drug effects / Q000502:physiology*; D015658:HIV Infections / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D006801:Humans; D011533:Proviruses / Q000187:drug effects / Q000502:physiology; D014766:Viremia / Q000188:drug therapy; D017735:Virus Latency; D014779:Virus Replication
chemical_list: D019380:Anti-HIV Agents
references.citation: Nat Med. 2009 Aug;15(8):893-900
references.pmid: 19543283
references.citation: AIDS. 2012 Nov 28;26(18):2295-306
references.pmid: 23014521
references.citation: Antivir Ther. 2012;17(2):355-64
references.pmid: 22290239
references.citation: Antimicrob Agents Chemother. 2014 Jul;58(7):3585-98
references.pmid: 24733471
references.citation: Nat Med. 2010 Apr;16(4):460-5
references.pmid: 20228817
references.citation: JAMA Intern Med. 2013 Apr 22;173(8):614-22
references.pmid: 23459863
references.citation: Nat Med. 2012 Nov;18(11):1682-7
references.pmid: 22972397
references.citation: HIV Med. 2014 Aug;15(7):406-16
references.pmid: 24460817
references.citation: PLoS One. 2009;4(10):e7658
references.pmid: 19876401
references.citation: Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12574-9
references.pmid: 9356491
references.citation: J Infect Dis. 1999 Oct;180(4):1347-50
references.pmid: 10479170
references.citation: Clin Infect Dis. 2014 Nov 1;59(9):1312-21
references.pmid: 25073894
references.citation: Nat Med. 2000 Jan;6(1):82-5
references.pmid: 10613829
references.citation: J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):808-16
references.pmid: 15213564
references.citation: PLoS One. 2012;7(5):e36673
references.pmid: 22590588
references.citation: J Infect Dis. 2008 Mar 1;197(5):714-20
references.pmid: 18260759
references.citation: AIDS. 2014 Jan 28;28(3):325-34
references.pmid: 24185044
references.citation: J Infect Dis. 2011 Aug 15;204(4):515-20
references.pmid: 21791652
references.citation: Clin Microbiol Infect. 2015 Mar;21(3):288.e5-7
references.pmid: 25658542
references.citation: AIDS. 1998 Sep 10;12(13):1619-24
references.pmid: 9764780
references.citation: J Int AIDS Soc. 2014;17(4 Suppl 3):19828
references.pmid: 25397572
references.citation: Scand J Immunol. 2008 Dec;68(6):652-60
references.pmid: 19055701
references.citation: Clin Infect Dis. 2013 Nov;57(10):1489-96
references.pmid: 23946221
references.citation: AIDS. 2014 Mar;28 Suppl 2:S217-24
references.pmid: 24849481
references.citation: AIDS. 2011 Nov 13;25(17):2069-78
references.pmid: 21860347
references.citation: AIDS. 2010 Nov 27;24(18):2803-8
references.pmid: 20962613
references.citation: Clinicoecon Outcomes Res. 2014 Jul 14;6:341-8
references.pmid: 25053888
references.citation: AIDS. 2011 Mar 13;25(5):665-9
references.pmid: 21326075
references.citation: Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):20-31
references.pmid: 16433887
references.citation: N Engl J Med. 1996 Feb 15;334(7):426-31
references.pmid: 8552144
references.citation: Curr HIV Res. 2008 May;6(3):261-6
references.pmid: 18473790
references.citation: AIDS Res Ther. 2014 Oct 07;11(1):33
references.pmid: 25320633
references.citation: Antimicrob Agents Chemother. 2012 Nov;56(11):5998-6000
references.pmid: 22890763
references.citation: J Med Virol. 2009 Mar;81(3):400-5
references.pmid: 19152404
references.citation: J Clin Microbiol. 2012 Feb;50(2):258-63
references.pmid: 22135262
references.citation: Nature. 1997 May 8;387(6629):183-8
references.pmid: 9144289
references.citation: HIV Med. 2006 Oct;7(7):437-41
references.pmid: 16925729
references.citation: Ann Intern Med. 1997 Jun 15;126(12):929-38
references.pmid: 9182469
references.citation: JAMA. 1997 Jun 25;277(24):1962-9
references.pmid: 9200638
references.citation: AIDS. 2014 Sep 24;28(15):2251-8
references.pmid: 25022595
references.citation: J Antimicrob Chemother. 2012 Sep;67(9):2231-5
references.pmid: 22643190
references.citation: J Clin Microbiol. 2013 May;51(5):1555-7
references.pmid: 23390288
references.citation: J Clin Virol. 2013 Aug;57(4):351-5
references.pmid: 23664725
references.citation: AIDS. 2014 Jan 14;28(2):181-6
references.pmid: 24361679
references.citation: J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):23-30
references.pmid: 16340469
references.citation: AIDS. 2004 Apr 30;18(7):981-9
references.pmid: 15096800
references.citation: Ann Intern Med. 1997 Jun 15;126(12):939-45
references.pmid: 9182470
references.citation: Science. 1996 May 24;272(5265):1167-70
references.pmid: 8638160
references.citation: J Infect Dis. 2004 Jan 15;189(2):312-21
references.pmid: 14722897
references.citation: J Infect Dis. 2005 May 1;191(9):1410-8
references.pmid: 15809898
references.citation: AIDS Res Hum Retroviruses. 2011 Apr;27(4):355-64
references.pmid: 21309730
references.citation: PLoS One. 2013;8(1):e53621
references.pmid: 23349724
references.citation: AIDS. 2014 Jan 14;28(2):201-8
references.pmid: 24361681
references.citation: Retrovirology. 2013;10:161
references.pmid: 24364896
references.citation: AIDS. 2011 Apr 24;25(7):885-97
references.pmid: 21422987
references.citation: Nat Med. 1995 Dec;1(12):1284-90
references.pmid: 7489410
references.citation: J Infect Dis. 2007 Jun 15;195(12):1762-4
references.pmid: 17492591
references.citation: Curr Opin HIV AIDS. 2013 Mar;8(2):106-10
references.pmid: 23314907
references.citation: J Infect Dis. 2013 Nov 1;208(9):1436-42
references.pmid: 23975885
references.citation: J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):153-60
references.pmid: 25072610
references.citation: J Antimicrob Chemother. 2012 Dec;67(12):2932-8
references.pmid: 22915460
references.citation: J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):407-16
references.pmid: 22902723
references.citation: J Antimicrob Chemother. 2014 Mar;69(3):753-6
references.pmid: 24187041
references.citation: HIV Med. 2013 Nov;14 Suppl 4:1-71
references.pmid: 24581304
references.citation: AIDS. 2013 Jun 19;27(10):1545-55
references.pmid: 24005375
references.citation: PLoS One. 2012;7(11):e50065
references.pmid: 23166820
references.citation: AIDS. 2004 Jan 2;18(1):45-9
references.pmid: 15090828
references.citation: AIDS. 2001 Jun 15;15(9):1181-3
references.pmid: 11416722
references.citation: AIDS. 2014 May 15;28(8):1125-34
references.pmid: 24451160
references.citation: AIDS Res Hum Retroviruses. 2014 Oct;30(10):936-44
references.pmid: 25055246
references.citation: JAMA. 1998 Jan 7;279(1):35-40
references.pmid: 9424041
references.citation: J Neurovirol. 2014 Dec;20(6):571-82
references.pmid: 25227930
references.citation: J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):473-82
references.pmid: 22481602
references.citation: Science. 1997 Nov 14;278(5341):1295-300
references.pmid: 9360927
references.citation: Clin Infect Dis. 2015 Jan 15;60(2):311-7
references.pmid: 25281609
references.citation: PLoS Pathog. 2013 Mar;9(3):e1003211
references.pmid: 23516360
references.citation: Blood. 2013 May 23;121(21):4321-9
references.pmid: 23589672
references.citation: Clin Infect Dis. 2012 Mar 1;54(5):724-32
references.pmid: 22238167
references.citation: AIDS. 2000 Jan 7;14(1):23-9
references.pmid: 10714564
references.citation: Ann Intern Med. 1997 Jun 15;126(12):946-54
references.pmid: 9182471
references.citation: J Med Virol. 2007 Jul;79(7):880-6
references.pmid: 17516532
references.citation: J Virol. 2014 Sep 1;88(17):10056-65
references.pmid: 24965451
references.citation: Clin Infect Dis. 2014 Apr;58(8):1165-73
references.pmid: 24429436
references.citation: J Clin Virol. 2008 Aug;42(4):399-404
references.pmid: 18455956
references.citation: Arch Public Health. 2014 Oct 27;72(1):37
references.pmid: 25671110
references.citation: Antivir Ther. 2015;20(2):165-75
references.pmid: 24964403
references.citation: Clin Infect Dis. 2014 Apr;58(8):1156-64
references.pmid: 24429430
references.citation: Top Antivir Med. 2013 Sep-Oct;21(4):128-32
references.pmid: 24225078
references.citation: J Allergy Clin Immunol. 2008 Jul;122(1):22-8
references.pmid: 18602567
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3879-84
references.pmid: 18332425
references.citation: HIV Med. 2012 Oct;13(9):568-73
references.pmid: 22435457
references.citation: Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9403-8
references.pmid: 19470482
references.citation: Clin Infect Dis. 2014 May;58(9):1297-307
references.pmid: 24457345
references.citation: Retrovirology. 2012;9:87
references.pmid: 23092122
references.citation: Clin Infect Dis. 2006 Mar 1;42(5):709-15
references.pmid: 16447119
references.citation: Cell. 2014 Aug 28;158(5):971-2
references.pmid: 25171398
references.citation: Clin Infect Dis. 2010 Mar 15;50(6):912-9
references.pmid: 20156060
references.citation: J Infect Dis. 2005 Feb 1;191(3):348-57
references.pmid: 15633093